Acadia Healthcare
- Market cap
- 2.72B
- P/E (TTM)i
- -2.35
- P/Bi
- 1.38
- EPSi
- -12.16
- Div yieldi
- 0.00%
- 52W posi
- 73%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 3.4 percentage points.
Institutional ownership
- Held by institutions
- 144.31% -3.37pp
- Institutions
- 370 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 14 sells
| Name | Role | Stake |
|---|---|---|
| Reeve Waud | Independent Chairperson | 0.74% |
| Brian Farley | General Counsel | 0.15% |
| John Hollinsworth | Officer | 0.12% |
| Todd Young | Chief Financial Officer | 0.12% |
| William Grieco | Independent Director | 0.10% |
| E. Bissell | Independent Director | 0.06% |
| Wade Miquelon | Independent Director | 0.06% |
| Christopher Hunter | Chief Executive Officer | 0.05% |
| Jason Bernhard | Independent Director | 0.05% |
| Vicky Gregg | Independent Director | 0.05% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-25 | Brian Farley | General Counsel | Sale to Issuer | -1,770 | $34.51 |
| 2026-06-25 | Brian Farley | General Counsel | Sale to Issuer | -1,370 | $26.24 |
| 2026-05-05 | Reeve Waud | Independent Chairperson | Other Acquisition | +15,907 | -- |
| 2026-05-05 | E. Bissell | Independent Director | Other Acquisition | +11,831 | -- |
| 2026-05-05 | William Grieco | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Jason Bernhard | Independent Director | Other Acquisition | +11,455 | -- |
| 2026-05-05 | Vicky Gregg | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Daniel Cancelmi | Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Ralph Kelly | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Patrice Harris | Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Michael Fucci | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-04 | Brian Farley | General Counsel | Sale to Issuer | -5,063 | $27.69 |
| 2026-04-30 | David Duckworth | Former Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-04-27 | Brian Farley | General Counsel | Other Acquisition | +37,510 | -- |
| 2026-04-09 | Brian Farley | General Counsel | Other Acquisition | +37,510 | -- |
| 2026-04-09 | Todd Young | Chief Financial Officer | Other Acquisition | +58,799 | -- |
| 2026-03-11 | Daniel Cancelmi | Director | Other Acquisition | +6,625 | -- |
| 2026-03-11 | Daniel Cancelmi | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-02-26 | Brian Farley | General Counsel | Sale to Issuer | -1,915 | $22.29 |
| 2026-01-19 | Debra Osteen | Director | Other Derivative Acquisition | +1,125,000 | $11.68 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:07:19 · For reference only, not investment advice and not tailored to your situation.